391 related articles for article (PubMed ID: 28511907)
1. Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives.
Altıntop MD; Sever B; Özdemir A; Kucukoglu K; Onem H; Nadaroglu H; Kaplancıklı ZA
Bioorg Med Chem; 2017 Jul; 25(13):3547-3554. PubMed ID: 28511907
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
[TBL] [Abstract][Full Text] [Related]
3. The synthesis of novel pyrazole-3,4-dicarboxamides bearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II.
Mert S; Alım Z; İşgör MM; Beydemir Ş; Kasımoğulları R
Bioorg Chem; 2016 Oct; 68():64-71. PubMed ID: 27454619
[TBL] [Abstract][Full Text] [Related]
4. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.
Kasimoğullari R; Bülbül M; Günhan H; Güleryüz H
Bioorg Med Chem; 2009 May; 17(9):3295-301. PubMed ID: 19362844
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 5-amino-1,3,4-thiadiazole-2-sulfonamide containing acridine sulfonamide/carboxamide compounds and investigation of their inhibition effects on human carbonic anhydrase I, II, IV and VII.
Aday B; Ulus R; Tanç M; Kaya M; Supuran CT
Bioorg Chem; 2018 Apr; 77():101-105. PubMed ID: 29353727
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of new thiadiazole derivatives as potential inhibitors of human carbonic anhydrase isozymes (hCA-I and hCA-II).
Altintop MD; Ozdemir A; Kucukoglu K; Turan-Zitouni G; Nadaroglu H; Kaplancikli ZA
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):32-7. PubMed ID: 24666301
[TBL] [Abstract][Full Text] [Related]
8. Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes.
Kucukoglu K; Gul HI; Taslimi P; Gulcin I; Supuran CT
Bioorg Chem; 2019 May; 86():316-321. PubMed ID: 30743172
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II.
Büyükkıdan N; Büyükkıdan B; Bülbül M; Kasımoğulları R; Mert S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):208-213. PubMed ID: 28114829
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors.
Kaya M; Basar E; Cakir E; Tunca E; Bülbül M
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):509-14. PubMed ID: 21846203
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives.
Sağlık BN; Çevik UA; Osmaniye D; Levent S; Çavuşoğlu BK; Demir Y; Ilgın S; Özkay Y; Koparal AS; Beydemir Ş; Kaplancıklı ZA
Bioorg Chem; 2019 Oct; 91():103153. PubMed ID: 31382057
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds.
Balaydin HT; Durdaği S; Ekinci D; Sentürk M; Göksu S; Menzek A
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):467-75. PubMed ID: 21815772
[TBL] [Abstract][Full Text] [Related]
17. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
[TBL] [Abstract][Full Text] [Related]
19. A class of sulfonamides as carbonic anhydrase I and II inhibitors.
Gokcen T; Gulcin I; Ozturk T; Goren AC
J Enzyme Inhib Med Chem; 2016; 31(sup2):180-188. PubMed ID: 27353698
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI.
Sentürk M; Ekinci D; Göksu S; Supuran CT
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):365-9. PubMed ID: 21699374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
